Homocysteine and mobility in older adults

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

OBJECTIVES: To determine the influence of homocysteine on mobility decline in older adults. DESIGN: Prospective cohort. SETTING: Einstein Aging Study, community-based aging study. PARTICIPANTS: Five hundred seventy-four older adults without dementia (mean age 80.2 ± 5.4, 61% women). MEASUREMENTS: Mobility decline defined using gait velocity measurements at baseline and annual follow-up visits. Linear mixed effects models were used to adjust for age, sex, education, and other potential confounders. RESULTS: Higher homocysteine levels were associated with slower gait velocity at baseline. Adjusted for age, sex, and education, a one-unit increase in baseline log homocysteine levels was associated with a 2.95-cm/s faster mobility decline per year (P=.01) over a median follow-up of 1.4 years. The 140 subjects in the highest quartile of homocysteine had a faster rate of mobility decline (1.75 cm/s per year faster, P=.01) than the 434 subjects in the lowest three quartiles of homocysteine (≤15 μmol/L). The association between homocysteine and mobility decline remained robust even after adjusting for multiple confounders and accounting for the presence of clinical gait abnormalities. CONCLUSION: Higher homocysteine levels are associated with greater risk of mobility decline in community-residing older adults.

Original languageEnglish (US)
Pages (from-to)545-550
Number of pages6
JournalJournal of the American Geriatrics Society
Volume58
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Homocysteine
Gait
Sex Education
Dementia

Keywords

  • Gait
  • Homocysteine
  • Mobility decline

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Homocysteine and mobility in older adults. / Rolita, Lydia; Holtzer, Roee; Wang, Cuiling; Lipton, Richard B.; Derby, Carol A.; Verghese, Joe.

In: Journal of the American Geriatrics Society, Vol. 58, No. 3, 03.2010, p. 545-550.

Research output: Contribution to journalArticle

@article{69185ed57b4b461c923de7d14c787709,
title = "Homocysteine and mobility in older adults",
abstract = "OBJECTIVES: To determine the influence of homocysteine on mobility decline in older adults. DESIGN: Prospective cohort. SETTING: Einstein Aging Study, community-based aging study. PARTICIPANTS: Five hundred seventy-four older adults without dementia (mean age 80.2 ± 5.4, 61{\%} women). MEASUREMENTS: Mobility decline defined using gait velocity measurements at baseline and annual follow-up visits. Linear mixed effects models were used to adjust for age, sex, education, and other potential confounders. RESULTS: Higher homocysteine levels were associated with slower gait velocity at baseline. Adjusted for age, sex, and education, a one-unit increase in baseline log homocysteine levels was associated with a 2.95-cm/s faster mobility decline per year (P=.01) over a median follow-up of 1.4 years. The 140 subjects in the highest quartile of homocysteine had a faster rate of mobility decline (1.75 cm/s per year faster, P=.01) than the 434 subjects in the lowest three quartiles of homocysteine (≤15 μmol/L). The association between homocysteine and mobility decline remained robust even after adjusting for multiple confounders and accounting for the presence of clinical gait abnormalities. CONCLUSION: Higher homocysteine levels are associated with greater risk of mobility decline in community-residing older adults.",
keywords = "Gait, Homocysteine, Mobility decline",
author = "Lydia Rolita and Roee Holtzer and Cuiling Wang and Lipton, {Richard B.} and Derby, {Carol A.} and Joe Verghese",
year = "2010",
month = "3",
doi = "10.1111/j.1532-5415.2010.02718.x",
language = "English (US)",
volume = "58",
pages = "545--550",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Homocysteine and mobility in older adults

AU - Rolita, Lydia

AU - Holtzer, Roee

AU - Wang, Cuiling

AU - Lipton, Richard B.

AU - Derby, Carol A.

AU - Verghese, Joe

PY - 2010/3

Y1 - 2010/3

N2 - OBJECTIVES: To determine the influence of homocysteine on mobility decline in older adults. DESIGN: Prospective cohort. SETTING: Einstein Aging Study, community-based aging study. PARTICIPANTS: Five hundred seventy-four older adults without dementia (mean age 80.2 ± 5.4, 61% women). MEASUREMENTS: Mobility decline defined using gait velocity measurements at baseline and annual follow-up visits. Linear mixed effects models were used to adjust for age, sex, education, and other potential confounders. RESULTS: Higher homocysteine levels were associated with slower gait velocity at baseline. Adjusted for age, sex, and education, a one-unit increase in baseline log homocysteine levels was associated with a 2.95-cm/s faster mobility decline per year (P=.01) over a median follow-up of 1.4 years. The 140 subjects in the highest quartile of homocysteine had a faster rate of mobility decline (1.75 cm/s per year faster, P=.01) than the 434 subjects in the lowest three quartiles of homocysteine (≤15 μmol/L). The association between homocysteine and mobility decline remained robust even after adjusting for multiple confounders and accounting for the presence of clinical gait abnormalities. CONCLUSION: Higher homocysteine levels are associated with greater risk of mobility decline in community-residing older adults.

AB - OBJECTIVES: To determine the influence of homocysteine on mobility decline in older adults. DESIGN: Prospective cohort. SETTING: Einstein Aging Study, community-based aging study. PARTICIPANTS: Five hundred seventy-four older adults without dementia (mean age 80.2 ± 5.4, 61% women). MEASUREMENTS: Mobility decline defined using gait velocity measurements at baseline and annual follow-up visits. Linear mixed effects models were used to adjust for age, sex, education, and other potential confounders. RESULTS: Higher homocysteine levels were associated with slower gait velocity at baseline. Adjusted for age, sex, and education, a one-unit increase in baseline log homocysteine levels was associated with a 2.95-cm/s faster mobility decline per year (P=.01) over a median follow-up of 1.4 years. The 140 subjects in the highest quartile of homocysteine had a faster rate of mobility decline (1.75 cm/s per year faster, P=.01) than the 434 subjects in the lowest three quartiles of homocysteine (≤15 μmol/L). The association between homocysteine and mobility decline remained robust even after adjusting for multiple confounders and accounting for the presence of clinical gait abnormalities. CONCLUSION: Higher homocysteine levels are associated with greater risk of mobility decline in community-residing older adults.

KW - Gait

KW - Homocysteine

KW - Mobility decline

UR - http://www.scopus.com/inward/record.url?scp=77949351364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949351364&partnerID=8YFLogxK

U2 - 10.1111/j.1532-5415.2010.02718.x

DO - 10.1111/j.1532-5415.2010.02718.x

M3 - Article

C2 - 20158558

AN - SCOPUS:77949351364

VL - 58

SP - 545

EP - 550

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 3

ER -